Weiss Asset Management LP Raises Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Weiss Asset Management LP boosted its position in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 50.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 912,818 shares of the company's stock after buying an additional 306,143 shares during the period. Weiss Asset Management LP owned approximately 1.06% of Pediatrix Medical Group worth $10,580,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MD. Quest Partners LLC raised its holdings in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after buying an additional 622 shares during the period. nVerses Capital LLC acquired a new position in Pediatrix Medical Group in the 2nd quarter worth about $31,000. Innealta Capital LLC acquired a new position in shares of Pediatrix Medical Group during the second quarter valued at approximately $33,000. Quarry LP grew its position in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,662 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in shares of Pediatrix Medical Group by 47.2% in the second quarter. Nisa Investment Advisors LLC now owns 4,755 shares of the company's stock valued at $36,000 after purchasing an additional 1,524 shares in the last quarter. 97.71% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The stock was sold at an average price of $15.35, for a total transaction of $423,660.00. Following the sale, the director now directly owns 138,683 shares in the company, valued at $2,128,784.05. The trade was a 16.60 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mary Ann E. Moore sold 8,108 shares of Pediatrix Medical Group stock in a transaction on Friday, November 8th. The stock was sold at an average price of $16.00, for a total value of $129,728.00. Following the sale, the executive vice president now owns 135,810 shares in the company, valued at $2,172,960. The trade was a 5.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.00% of the company's stock.

Pediatrix Medical Group Price Performance

Shares of MD stock traded up $0.04 during mid-day trading on Friday, reaching $14.74. The company's stock had a trading volume of 204,088 shares, compared to its average volume of 856,352. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $16.41. The company has a market cap of $1.27 billion, a P/E ratio of -4.82, a PEG ratio of 2.10 and a beta of 1.57. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.42 and a current ratio of 1.42. The firm's 50-day moving average is $13.66 and its two-hundred day moving average is $10.44.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Friday, November 1st. The company reported $0.44 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.07. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm had revenue of $511.20 million during the quarter, compared to analysts' expectations of $498.87 million. During the same quarter last year, the company posted $0.29 EPS. The company's quarterly revenue was up .9% compared to the same quarter last year. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have commented on MD. Truist Financial upped their price target on Pediatrix Medical Group from $13.00 to $16.00 and gave the stock a "hold" rating in a research note on Monday, November 4th. Jefferies Financial Group raised their price objective on Pediatrix Medical Group from $14.00 to $18.00 and gave the stock a "buy" rating in a report on Tuesday, November 5th. Deutsche Bank Aktiengesellschaft raised their price target on Pediatrix Medical Group from $9.00 to $15.00 and gave the stock a "hold" rating in a report on Monday, November 4th. UBS Group increased their target price on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a research note on Tuesday, November 5th. Finally, Mizuho increased their target price on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a report on Tuesday, November 19th. Five equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $16.10.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.